Biogenerics Bill From Reps. Eshoo And Barton “Expects” Limits On Substitution

Interchangeability standards that come close to those sought by the Bush administration are contained in follow-on biologics legislation that is expected to be introduced shortly by Rep. Anna Eshoo, D-Calif

Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

More from Archive

More from Pink Sheet